Jacek S Malyszko
Overview
Explore the profile of Jacek S Malyszko including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
76
Citations
556
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Malyszko J, Malyszko J, Wojtaszek E
Pol Arch Intern Med
. 2024 May;
134(5).
PMID: 38804243
No abstract available.
2.
Zawierucha J, Marcinkowski W, Prystacki T, Malyszko J, Pyrza M, Zebrowski P, et al.
Kidney Blood Press Res
. 2023 May;
48(1):385-391.
PMID: 37166319
Background: Hemodialysis is one of the most resources consuming medical intervention. Due to its concept, the proper amount of dialysis fluid passed through dialyzer is crucial to obtain the expected...
3.
Marcinkowski W, Zuzda K, Zawierucha J, Prystacki T, Zebrowski P, Malyszko J, et al.
Vaccines (Basel)
. 2022 Sep;
10(9).
PMID: 36146642
Patients with end-stage kidney disease undergoing hemodialysis are particularly vulnerable to severe COVID-19 as a result of older age and multimorbidities. Data are still limited and there are no published...
4.
Milkowski A, Prystacki T, Marcinkowski W, Dryl-Rydzynska T, Zawierucha J, Malyszko J, et al.
Ren Fail
. 2022 Jun;
44(1):946-957.
PMID: 35652160
The phenomenon of patients with advanced renal failure accepted for dialysis at a late stage in the disease process (late referral [LR]) is known almost from the beginning of dialysis...
5.
Golenia A, Malyszko J, Malyszko J
Kidney Blood Press Res
. 2022 Apr;
47(7):459-466.
PMID: 35447625
Background: Chronic kidney disease (CKD) affects the crosstalk between organs in the body and vast majority of studies were devoted to the interactions between the kidneys and the cardiovascular system....
6.
Bnaya A, Shavit L, Malyszko J, Malyszko J, Slotki I
Ther Apher Dial
. 2019 Nov;
24(4):416-422.
PMID: 31762187
The increased usage of intravenous iron in hemodialysis patients during recent years has led to increasing concern over the potential development of iron overload. Current methods for detecting iron overload,...
7.
Malyszko J, Malyszko J, Matuszkiewicz-Rowinska J
Expert Opin Ther Targets
. 2019 Mar;
23(5):407-421.
PMID: 30907175
Anemia is a common manifestation of chronic kidney disease (CKD). The pathogenesis of CKD-associated anemia is multifactorial. Our understanding of the molecular control of iron metabolism has improved dramatically because...
8.
Malyszko J, Bachorzewska-Gajewska H, Malyszko J, Koc-Zorawska E, Matuszkiewicz-Rowinska J, Dobrzycki S
Adv Med Sci
. 2019 Mar;
64(2):211-215.
PMID: 30818219
Purpose: Contrast-induced acute kidney injury (CI-AKI) is a common and potentially serious complication of percutaneous coronary interventions (PCI). In this study, we tested the hypothesis whether serum and urinary hepcidin...
9.
Zawierucha J, Malyszko J, Malyszko J, Prystacki T, Marcinkowski W, Dryl-Rydzynska T
Front Endocrinol (Lausanne)
. 2019 Feb;
10:40.
PMID: 30804890
Secondary hyperparathyroidism (sHPT) is a common hormonal complication of chronic kidney disease. There are several therapeutic options for sHPT management aiming at calcium-phosphorus balance normalization and decrease of parathormone secretion....
10.
Batko K, Malyszko J, Jurczyszyn A, Vesole D, Gertz M, Leleu X, et al.
Nephrol Dial Transplant
. 2018 Sep;
34(9):1440-1452.
PMID: 30169860
Monoclonal gammopathy of renal significance (MGRS) has introduced a new perspective to several well-known disease entities impacting nephrology, haematology and pathology. Given the constantly changing disease spectrum of these entities,...